Real-time enrollment status for this hidradenitis suppurativa (hs) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:24 PM UTC
| NCT Number | NCT07384975 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa (HS) |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Navigator Medicines, Inc. |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of October 12, 2026: Clinical trial NCT07384975 is currently recruiting participants. This phase2 study for hidradenitis suppurativa (hs) is actively seeking new participants at 14 locations across the United States. The study is sponsored by Navigator Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07384975 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07384975 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.